C3894683||Extracellular vesicles
C0005953||bone marrow
C1257975||mesenchymal stem cells
C0026809||murine
C4303160||hepatic ischemia - reperfusion injury
C4303160||Hepatic ischemia-reperfusion injury
C4303160||ischemia-reperfusion injury
C0021368||associated inflammation
C0086565||liver dysfunction
C0009566||complications
C0193373||liver surgery
C0040732||transplantation
C1257975||Mesenchymal stem cells
C1257975||Mesenchymal stem cells
C4303160||hepatic IRI
C1527392||immunomodulatory
C0040300||tissues
C3894683||extracellular vesicles
C1257975||MSCs
C1257975||Mesenchymal stem cells
C3894683||EV
C1511243||mouse bone marrow
C1257975||Mesenchymal stem cells
C3894683||EV
C0887965||experimental murine model
C4303160||hepatic IRI
C0019145||hepatic artery
C0032718||portal vein
C0035124||reperfusion
C0013125||controls, intravenous administration
C1257975||Mesenchymal stem cells
C3894683||EV
C4303160||ischemia-reperfusion injury
C0027540||tissue necrosis
C0291573||caspase-3 positive
C3269134||apoptotic cells
C0002594||aminotransferase
C1257975||Mesenchymal stem cells
C3894683||EV
C0205054||hepatic
C1515670||mRNA expression
C1864814||NACHT, LRR and PYD domains-containing protein 12
C1864814||Nlrp12
C0812445||chemokine (C-X-C motif) ligand 1
C0812445||CXCL1
C1515670||mRNA expression
C0079189||cytokines
C0021760||IL-6
C4303160||ischemia-reperfusion injury
C1257975||Mesenchymal stem cells
C3894683||EV
C0007620||cell viability
C0961340||NF-ÎºB
C0227525||AML12 murine hepatocytes
C1533734||administration
C3894683||EV
C0005953||bone marrow
C1257975||MSCs
C0243095||ameliorate
C4303160||hepatic IRI
C0160390||hepatic injury
C0443264||modulation
C1155266||inflammatory response